Tommy Fornander

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Tamoxifen therapy benefit in luminal A and B breast cancer with 20-year follow-up.

Tamoxifen therapy benefit in luminal A and B breast cancer with 20-year follow-up.

Journal: Journal of the National Cancer Institute

Published: October 13, 2025

Long-term benefit from adjuvant tamoxifen therapy for ER+ HER2- breast cancer by PR positivity.

Long-term benefit from adjuvant tamoxifen therapy for ER+ HER2- breast cancer by PR positivity.

Journal: International journal of cancer

Published: July 05, 2025

Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index.

Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 15, 2024

Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial.

Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial.

Journal: International journal of cancer

Published: October 25, 2024

Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.

Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 17, 2024

Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial.

Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial.

Journal: Journal of the National Cancer Institute

Published: May 02, 2024

GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer.

GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer.

Journal: NPJ breast cancer

Published: April 17, 2024

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up.

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up.

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 05, 2024

Short Bouts of Physical Activity-Good for Health?

Short Bouts of Physical Activity-Good for Health?

Journal: JAMA oncology

Published: July 27, 2023

Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy.

Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy.

Journal: Breast (Edinburgh, Scotland)

Published: May 21, 2023

Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2-Negative Postmenopausal Breast Cancer Patients.

Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2-Negative Postmenopausal Breast Cancer Patients.

Journal: Cancers

Published: August 22, 2022

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 21, 2022

Showing 1-12 of 60

Last Updated: 09/26/2026